Cumberland Pharmaceuticals (CPIX) Shares Outstanding (Diluted) (2010 - 2026)
Powered by 
Analysis
Cumberland Pharmaceuticals (CPIX) Shares Outstanding (Diluted) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.53 Bn | 625.77 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 442.27 Bn | 435.70 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 366.81 Bn | 359.67 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 266.82 Bn | 259.13 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Pfizer | 159.37 Bn | 147.67 Bn | 10.94 Bn | 5.70 Bn |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn | 1.23 Bn |
| 7 | Revolution Medicines | 44.12 Bn | 44.12 Bn | - | 210.89 Mn |
| 8 | Incyte | 25.49 Bn | 20.95 Bn | 1.57 Bn | 208.22 Mn |
| 9 | United Therapeutics | 21.55 Bn | 18.89 Bn | 683.80 Mn | 45.80 Mn |
| 10 | Cumberland Pharmaceuticals | 96.11 Mn | 92.24 Mn | - | 14.98 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.98 Mn |
| Mar 31, 2026 | 14.96 Mn |
| Dec 31, 2025 | 14.85 Mn |
| Sep 30, 2025 | 14.96 Mn |
| Jun 30, 2025 | 14.96 Mn |
| Mar 31, 2025 | 15.26 Mn |
| Dec 31, 2024 | 14.06 Mn |
| Sep 30, 2024 | 14.05 Mn |
| Jun 30, 2024 | 14.12 Mn |
| Mar 31, 2024 | 14.10 Mn |
| Dec 31, 2023 | 14.30 Mn |
| Sep 30, 2023 | 14.28 Mn |
| Jun 30, 2023 | 14.55 Mn |
| Mar 31, 2023 | 14.59 Mn |
| Dec 31, 2022 | 14.56 Mn |
| Sep 30, 2022 | 14.48 Mn |
| Jun 30, 2022 | 14.69 Mn |
| Mar 31, 2022 | 14.69 Mn |
| Dec 31, 2021 | 14.90 Mn |
| Sep 30, 2021 | 14.88 Mn |